Vital Signs
FDA Approves First “Bloodless” Rapid HIV Test
When rapid HIV diagnostic tests, which deliver results in about 20 minutes, were first approved for use in the U.S., they were hailed as a major breakthrough in increasing early detection of the HIV virus and preventing the spread of AIDS by people who are unaware that they are HIV-positive. According to Department of Health and Human Services Secretary Tommy G. Thompson, “Before the approval of [rapid tests], many people being tested for HIV in public clinics did not return for the results of standard tests [which usually took a week to provide results]. Where the rapid test is available, those tested get their results within minutes.”
Now this important advance in AIDS screening has been taken one step further. On March 26, the Food and Drug Administration (FDA) approved the first oral fluid-based rapid HIV test kit. Previously, all rapid HIV tests required the use of blood samples in order to get such fast results. The oral test, designed for use in point-of-care settings, has two distinct advantages. It provides a new option for people who may have avoided being screened because they were afraid of blood testing, and it reduces health care workers’ risk of being accidentally exposed to the HIV virus through needlesticks.
The test, called the OraQuick® Rapid HIV-1/2 Antibody Test, works by having the person being tested swab his/her gums with the testing device, which has an absorbent pad at one end. Then the health care worker inserts the device into a vial containing a solution. In 20 minutes, the test will indicate if HIV-1 antibodies are present by displaying two reddish-purple lines in a small window on the device. If the OraQuick test indicates a positive reading, that result must be confirmed with an additional, more specific test.
The new rapid oral HIV test is manufactured by OraSure Technologies, Inc., of Bethlehem, Pa., which also produced the first blood-based rapid HIV test to receive FDA approval. For more information, visit the company’s Web site at www.orasure.com.
Similar Articles
Featured Content
ACADEMIC PROGRAM
SCHOOL: Hunter-Bellevue School of Nursing DEGREES: Graduate DESCRIPTION:The Hunter-Bellevue School of Nursing prepares professionals to meet the needs of 21st century urban populations. Hunter-Bellevue School of Nursing is the largest public-sector nursing institution in New York, a unit of Hunter College, the largest senior college in the City University of New York. School of Nursing faculty are leaders in their fields who bring evidence-based clinical experience, research and teaching directly into the classroom while engaging students in solving real-world problems.
READ MORE READ ALLEVENT
TITLE: Hispanic Nurses: Transforming Policy to Support Healthy Communities for Hispanics ORGANIZATION: 35th Annual National Association Of Hispanic Nurses ConferenceJOB POSTING
POSITION: Nurse-Midwifery Tenure Track Faculty Member EMPLOYER: University of California, San Francisco, School of Nursing, Department of Family Health Care Nursing DESCRIPTION:Nurse-Midwifery Tenure Track Faculty Member
Assistant, Associate, or Full Professor Rank*
Education:
Minimum criteria:
1. Doctoral degree in nursing or related field.
2. Graduate level education and training in midwifery specialty.
3. Certification as a midwife from the American College of Nurse Midwives.
Highly desirable criteria:
READ MORE READ ALL